Relmada Therapeutics, Inc. (RLMD) Earnings
NASDAQ·Healthcare·Biotechnology
$5.50
+3.96%
Mkt Cap $556.97M
EPS — Estimate vs Actual
Mkt Cap
$556.97M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11
NASDAQ·Healthcare·Biotechnology
$5.50
+3.96%
Mkt Cap $556.97M
Mkt Cap
$556.97M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11